Mobile website
Archive > Volume 31 Issue 7 > 2024,31(7):662-668. DOI:10.3872/j.issn.1007-385X.2024.07.003 Prev Next
Basic Research
DKK1 blockade improves anti-tumor immune response by promoting Th1 type polarization of CD4+ T cells
- Article
- Figures
- Metrics
- Preview PDF
- Reference
- Related
- Cited by
- Materials
Abstract:
Objective: To explore the effect of Dickkopf-1 (DKK1) expression on CD4+ T cell polarization in malignant tumors and its potential value as a target for cancer immunotherapy. Methods: Bioinformatics algorithm was used to analyze the expression of DKK1 in multiple types of tumor tissues and adjacent tissues, and the correlation between the expression of DKK1 and the prognosis of cancer patients and immune infiltration of tumor microenvironment. The effect of DKK1 protein on the phenotype of CD4+ T cells was analyzed by flow cytometry in vitro. A melanoma B16F10 cell mouse subcutaneous transplantation tumor model was established to observe the effects of blocking DKK1 on the growth of mouse transplantation tumor and immune cell infiltration and phenotype in transplantation tumor tissues. Results: The mRNA expression levels of DKK1 in many kinds of tumor tissues were significantly higher than those in adjacent tissues. High expression of DKK1 was related to the poor prognosis of most tumor patients. In most types of tumors DKK1 played important negative regulatory role in CD4+ T cell anti-tumor immune response（ PP<0.01）. The results of flow cytometry in vitro showed that DKK1 protein stimulation significantly decreased the expression levels of T-bet, IFN-γ and CD107a in CD4+ T cells (all PP+ CD4+ ) increasing significantly (P+ T cells (CD44+ CD62L- ) increasing significantly (P+ CD4+ ) and Treg cells decreasing significantly (both PConclusion: Blocking DKK1 can effectively promote the phenotypic polarization of CD4+ T cells to Th1. DKK1 has potential value as a target for tumor immunotherapy.
Keywords:
Project Supported:
Clc Number:
